soul trial oral semaglutide cardiovascular outcomes 2024 results nejm

soul trial oral semaglutide cardiovascular outcomes 2024 results nejm (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine soul trial oral semaglutide cardiovascular

Name: soul trial oral semaglutide cardiovascular outcomes 2024 results nejm (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine soul trial oral semaglutide cardiovascular
Brand: truyentop.art
SKU: 32521026886
Price: 26.68 USD
Availability: InStock
Rating: 4.486000000000001 (6 reviews)

SKU: 32521026886

4.5

EUR26.68 EUR60.68

Pay in 4 interest-free payments of $6.67 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

These findings showcase the need for careful consideration and monitoring of patients prescribed semaglutide, given the elevated risks of serious eye conditions associated with its use